ClinicalTrials.Veeva

Menu

Effect of Tumor Base Size in Bladder Cancer

A

Ankara Training and Research Hospital

Status

Completed

Conditions

Bladder Cancer

Treatments

Procedure: TUR-BT

Study type

Interventional

Funder types

Other

Identifiers

NCT06632340
BCTB2024

Details and patient eligibility

About

Investigators aim to investigate the effect of the size of the base of the tumor in contact with the bladder mucosa on recurrence and progression in non-muscle invasive bladder tumors.

Full description

Between March 2021 and September 2023, 130 patients who applied to our clinic with complaints of hematuria, dysuria, and suprapubic pain, and who were diagnosed with bladder tumor by imaging methods and underwent TUR-MT were included in the study. The groups were compared in terms of age, gender, smoking, ASA, comorbidities, BMI and the number of tumors, size, stage as intraoperative and postoperative data. Patients with tumor base size <2 cm were classified as Group

1, while with tumor base size ≥2 cm were classified as Group 2. Kaplan Meier survival analysis without recurrence and without progression were performed after comparing the groups in terms of recurrence and progression.

Enrollment

130 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bladder Tumor

Exclusion criteria

  • Invasive Bladder Tumor

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

130 participants in 2 patient groups

Group 1
Other group
Description:
tumor base size \<2 cm
Treatment:
Procedure: TUR-BT
Group 2
Other group
Description:
tumor base size \>2 cm
Treatment:
Procedure: TUR-BT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems